Resmed (RMD) 4: Farrell Michael J. bought 13,547 shares at $0.00 on 2026-08… (Oct 1, 2026)

=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-08-14 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: RESMED INC (RMD) CIK: 0000943819 --- Reporting Owner --- Name: Farrell Michael J. CIK: 0001485164 Role: Director, Officer (Chairman and CEO) --- Non-Derivative Transactions --- [Transaction #1] Security: ResMed Common Stock Date: 2026-08-14 | Code: A (Grant or award) Shares: +13,547 | Price: $0.00 Shares Owned After: 479,803 | Ownership: D (Direct) Footnotes: [F1] Represents performance-based restricted stock units granted on November 20, 2025. The shares were earned on August 14, 2026, when the compensation committee certified that the performance metrics were met. Stock units vest 1/3 each year on the anniversary of the grant. --- Holdings --- [Holding #1] Security: ResMed Common Stock Ownership: I (Indirect) --- Footnotes (Complete Index) --- F1: Represents performance-based restricted stock units granted on November 20, 2025. The shares were earned on August 14, 2026, when the compensation committee certified that the performance metrics were met. Stock units vest 1/3 each year on the anniversary of the grant. --- Signature --- /s/ /s/ Lisa Beyer, attorney-in-fact for Mr. Farrell (2026-10-01)